Global Single-cell Technologies Market

Report Highlights

The global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a compound annual growth rate (CAGR) of 17.1% from 2024 through 2029.

Report Includes

• 33 data tables and 48 additional tables
• An analysis of the global single-cell technologies market
• Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024 and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects, along with a market share analysis based on product, techniques, cell type, application, end user and region
• Facts and figures on industry growth drivers, opportunities and restraints; the regulatory scenario; and the competitive landscape
• An analysis of patents related to single-cell technologies
• Overview of ESG and sustainability trends, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
• Company profiles of major players within the industry, including 10x Genomics, BD, and Thermo Fisher Scientific Inc.

Report Scope

This report provides detailed information about the single-cell technologies market. The report provides market projections for 2029 and the market share for key market players. The report details the market size of single-cell technologies based on product, cell type, techniques, application, and end user. The market is segmented by product into consumables and instruments. By cell type, it is classified into human cells, animal cells and microbial cells. By techniques, it encompasses flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. By application, it is segmented into research applications and medical applications. Also, by end user, it is categorized into research and academic laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.